CLS Holdings USA, Inc. Quarterly Current Ratio in % from Q1 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
CLS Holdings USA, Inc. quarterly Current Ratio history and growth rate from Q1 2014 to Q3 2024.
  • CLS Holdings USA, Inc. Current Ratio for the quarter ending August 31, 2024 was 30.3 %, a 17.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 30.3 -6.53 -17.7% Aug 31, 2024
Q2 2024 27.5 -4.97 -15.3% May 31, 2024
Q1 2024 28.6 -2.1 -6.84% Feb 29, 2024
Q4 2023 30.4 +1.89 +6.64% Nov 30, 2023
Q3 2023 36.9 +10.8 +41.6% Aug 31, 2023
Q2 2023 32.5 -0.16 -0.49% May 31, 2023
Q1 2023 30.7 -11.4 -27.1% Feb 28, 2023
Q4 2022 28.5 -11.4 -28.6% Nov 30, 2022
Q3 2022 26 -25.8 -49.8% Aug 31, 2022
Q2 2022 32.7 -33.1 -50.4% May 31, 2022
Q1 2022 42.1 -43 -50.5% Feb 28, 2022
Q4 2021 39.9 -196 -83.1% Nov 30, 2021
Q3 2021 51.8 -252 -82.9% Aug 31, 2021
Q2 2021 65.8 -191 -74.4% May 31, 2021
Q1 2021 85.1 -127 -60% Feb 28, 2021
Q4 2020 236 +42.2 +21.8% Nov 30, 2020
Q3 2020 303 +138 +83.2% Aug 31, 2020
Q2 2020 257 +108 +72.1% May 31, 2020
Q1 2020 213 +91.1 +75% Feb 29, 2020
Q4 2019 193 +123 +173% Nov 30, 2019
Q3 2019 166 +110 +197% Aug 31, 2019
Q2 2019 149 +144 +2687% May 31, 2019
Q1 2019 121 +115 +1824% Feb 28, 2019
Q4 2018 70.9 +64.4 +1001% Nov 30, 2018
Q3 2018 55.8 +53.6 +2402% Aug 31, 2018
Q2 2018 5.36 +3.13 +140% May 31, 2018
Q1 2018 6.31 +3.7 +142% Feb 28, 2018
Q4 2017 6.44 +3.07 +91.2% Nov 30, 2017
Q3 2017 2.23 -1.74 -43.9% Aug 31, 2017
Q2 2017 2.24 -3.23 -59.1% May 31, 2017
Q1 2017 2.61 -6.59 -71.6% Feb 28, 2017
Q4 2016 3.37 -7.46 -68.9% Nov 30, 2016
Q3 2016 3.97 Aug 31, 2016
Q2 2016 5.46 May 31, 2016
Q1 2016 9.2 Feb 29, 2016
Q4 2015 10.8 Nov 30, 2015
Q3 2014 0 Aug 31, 2014
Q2 2014 0 May 31, 2014
Q1 2014 0* Feb 28, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.